Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

TSX:ATE - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Page 44
View:
Post by MrMugsy on Feb 03, 2024 6:10pm

Page 44

Check out Page 44 of the presentation.
Does anyone see something interesting calling out to us ?
Comment by Harper75 on Feb 04, 2024 6:02pm
Are you seeing an Aspirin angle??  
Comment by MrMugsy on Feb 04, 2024 8:04pm
I am !!!! Let's find a manageable chronic path (daily dosing) - either full-chronic or chronic flare-up only (or both) ... with low-dose and placebo pills in the blister to protect the liver as need be. Then you dial down the chronic blister even further ... to offer it safely with low-dose ASPIRIN. Do the same with Mesalamine on the IBD side ... OTENA + Mesalamine. Etc. That would go a ...more  
Comment by Harper75 on Feb 05, 2024 2:01pm
When do you see strategy confirmation?  Along with Phase 2 read-out?   Would be nice for the market to see the potential the way you do..we do..  
Comment by MrMugsy on Feb 05, 2024 5:44pm
Making a 3-day and a 7-day to accompany the 5-day is the initial confirmation of what's possbile with blister packs.  This can then be tailored in the future for other things. What they need now is a 28-day for the daily.  That's what I'm looking for as the next-step confirmation.  If it isn't too complex, go right to the chronic and work back. Let's see if ...more  
Antibe Therapeutics Inc(Pre-Merger)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities